Literature DB >> 9342555

Prescribing patterns for nursing home residents in the US. The reality and the vision.

E Broderick1.   

Abstract

The study of prescribing for the elderly in the US is in its infancy. Nursing home studies provide some of the most reliable data. In US nursing homes, each resident is prescribed an average of between 7.2 and 8.1 medications, with gastrointestinal agents being the most frequent. The vision for prescribing in the US involves avoidance of polypharmacy and specific groups of medications. Approaches to treatment in the US for certain conditions that can be prevented are addressed, specifically pain control, osteoporosis, stroke, cardiovascular disease, cognitive impairment and infection.

Entities:  

Mesh:

Year:  1997        PMID: 9342555     DOI: 10.2165/00002512-199711040-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  53 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

Review 2.  Drug use in the nursing home.

Authors:  J Avorn; J H Gurwitz
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

3.  Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.

Authors:  D W Kaufman; J P Kelly; J E Sheehan; A Laszlo; B E Wiholm; L Alfredsson; R S Koff; S Shapiro
Journal:  Clin Pharmacol Ther       Date:  1993-04       Impact factor: 6.875

4.  Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  J Lynn; J M Teno; R S Phillips; A W Wu; N Desbiens; J Harrold; M T Claessens; N Wenger; B Kreling; A F Connors
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

5.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

Review 6.  Pain in the nursing home.

Authors:  W M Stein; B A Ferrell
Journal:  Clin Geriatr Med       Date:  1996-08       Impact factor: 3.076

7.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

8.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE)

Authors:  V L Handa; R Landerman; J T Hanlon; T Harris; H J Cohen
Journal:  J Am Geriatr Soc       Date:  1996-01       Impact factor: 5.562

10.  Acute care costs of the oldest old: they cost less, their care intensity is less, and they go to nonteaching hospitals.

Authors:  T T Perls; E R Wood
Journal:  Arch Intern Med       Date:  1996-04-08
View more
  3 in total

Review 1.  Assessing medication appropriateness in the elderly: a review of available measures.

Authors:  P S Shelton; M A Fritsch; M A Scott
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist.

Authors:  Victoria Rollason; Nicole Vogt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial.

Authors:  Mark Loeb; Kevin Brazil; Lynne Lohfeld; Allison McGeer; Andrew Simor; Kurt Stevenson; Stephen Walter; Dick Zoutman
Journal:  BMC Health Serv Res       Date:  2002-09-03       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.